NYRx, the Medicaid Pharmacy Program

Electronic prior authorizations are now accepted by NYRx, the Medicaid Pharmacy Program via CoverMyMeds®. Consider this alternative option as an effective and efficient way to request a PA other than by phone or by fax. For more information, contact NYRx Education & Outreach at NYRxEO@primetherapeutics.com.

Introduction

The Clinical Drug Review Program (CDRP) is aimed at ensuring specific drugs are utilized in a medically appropriate manner.

Under the CDRP, certain drugs require prior authorization because there may be specific safety issues, public health concerns, the potential for fraud and abuse or the potential for significant overuse and misuse.

Prior Authorization

Prior authorization for PDP drug classes subject to the CDRP must be obtained through a representative at the clinical call center. Prior authorization is required for original prescriptions, not refills. For some drugs subject to the CDRP, only prescribers, not their authorized agents, can initiate the prior authorization process. An authorized agent is an employee of the prescribing practitioner and has access to the patient's medical records (i.e. nurse, medical assistant).

Fax requests for prior authorization are not permitted. Each drug class has specific clinical information that must be provided to the clinical call center before prior authorization will be issued. Prescribers may be asked to fax that information. Clinical guidelines for the CDRP as well as prior authorization worksheets are available online at http://newyork.fhsc.com/providers/CDRP_forms.asp.

The following are subject to the Clinical Drug Review Program prior authorization requirements:

• Anabolic Steroids

For questions and comments:

• Visit https://newyork.fhsc.com/contactus.asp,
• Call Medicaid's pharmacy program at 518-486-3209, or
• E-mail ppno@health.ny.gov (please note "Clinical Drug Review Program" in the subject area).